Universal Health Services Inc (UHS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $11.40B
Last updated: Nov 17, 2026 at 4:20 PM ET
Universal Health Services Inc (UHS) Statistics
Universal Health Services (UHS) has a market cap of $11.40B and an enterprise value of $17.33B. Its share count is down 6.64% from a year earlier. Its trailing P/E of 8.5x is below its 10-year median of 12.8x.
Total Valuation
Enterprise value is 51.98% above the market cap, as debt exceeds cash.
| Market Cap | $11.40B |
|---|---|
| Enterprise Value | $17.33B |
| Latest price (Nov 17, 2026) | $191.98 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 1, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Last Ex-Dividend Date | Sep 1, 2026 |
| Last Payment Date | Sep 15, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.6x and 1.5x. Its year-end P/E ranged from 10.0x to 15.1x from 2016 to 2025.
| P/E Ratio | 8.5x |
|---|---|
| Forward P/E | 8.4x |
| P/S Ratio | 0.6x |
| Forward P/S | 0.6x |
| P/B Ratio | 1.5x |
| P/TBV Ratio | 3.9x |
| P/FCF Ratio | 10.1x |
| P/OCF Ratio | 5.5x |
| PEG Ratio | 1.2 |
Enterprise Valuation
Counting debt and cash, the company is valued at 6.2x EBITDA and 15.4x free cash flow.
| EV / Earnings | 11.7x |
|---|---|
| EV / Sales | 0.9x |
| EV / EBITDA | 6.2x |
| EV / EBIT | 8.2x |
| EV / FCF | 15.4x |
Price Statistics
The stock is down 14.54% over 52 weeks and trades 5.40% above its 50-day average.
| Beta (1Y) | 0.15 |
|---|---|
| 52-Week Change | -14.54% |
| 1-Month Change | +5.32% |
| 3-Month Change | +11.53% |
| 6-Month Change | +15.63% |
| 5-Year Change | +41.86% |
| 10-Year Change | +45.85% |
| Total Return (1Y) | -14.18% |
| Total Return (3Y CAGR) | +12.52% |
| Total Return (5Y CAGR) | +9.29% |
| Return vs SPY (1Y) | -27.51% |
| Max Drawdown (1Y) | -42.15% |
| Max Drawdown (3Y) | -42.15% |
| Sharpe Ratio (1Y) | -0.51 |
| Correlation with SPY (1Y) | 0.06 |
| 50-Day Average | $182.15 |
| 200-Day Average | $176.17 |
| 52-Week Range | $139.92 to $245.26 |
| RSI (14 Days) | 54.7 |
| Average Volume (20 Days) | 787.78K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.37x current liabilities, and total debt is 0.80x shareholder equity.
| Current Ratio | 1.37x |
|---|---|
| Quick Ratio | 1.28x |
| Debt / Equity | 0.80x |
| Debt / EBITDA | 2.19x |
| Debt / FCF | 5.47x |
| Interest Coverage | 12.07x |
Returns and Efficiency
Return on invested capital is 11.82% over the last 12 months, against a 5-year average of 10.09%.
| Return on Equity (ROE) | 19.54% |
|---|---|
| Return on Assets (ROA) | 8.64% |
| Return on Invested Capital (ROIC) | 11.82% |
| Return on Capital Employed (ROCE) | 14.62% |
| ROE (5Y Average) | 15.45% |
| ROA (5Y Average) | 7.07% |
| ROIC (5Y Average) | 10.09% |
| Asset Turnover | 1.13x |
| Inventory Turnover | 36.14x |
| Receivables Turnover | 6.54x |
| Cash Conversion Cycle | -41 days |
Taxes
Income tax took 23.62% of pretax income over the last 12 months.
| Income Tax (TTM) | $459.16M |
|---|---|
| Effective Tax Rate | 23.62% |
Scores
UHS has an Altman Z-Score of 2.26, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.26 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $18.35B over the last 12 months is up 8.00% from the 12 months before.
| Revenue | $18.35B |
|---|---|
| Revenue Growth (YoY) | +8.00% |
| Gross Profit | $9.87B |
| Operating Income | $1.99B |
| Pretax Income | $1.94B |
| Net Income | $1.48B |
| EBITDA | $2.78B |
| EBIT | $2.12B |
| Reported EPS (TTM) | $22.70 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 44.21% of the $17.19B in total assets.
| Cash and Equivalents | $168.75M |
|---|---|
| Total Debt | $6.10B |
| Net Debt | $5.93B |
| Net Debt Per Share | $100.82 |
| Working Capital | $992.81M |
| Shareholder Equity | $7.60B |
| Book Value Per Share | $129.21 |
| Tangible Book Value | $2.86B |
| Tangible Book Per Share | $48.64 |
| Total Assets | $17.19B |
| Total Liabilities | $9.44B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $940.95M of capital spending, operating cash flow left $1.12B of free cash flow.
| Operating Cash Flow | $2.06B |
|---|---|
| Capital Expenditures | $940.95M |
| Free Cash Flow | $1.12B |
| FCF Per Share | $21.58 |
| Depreciation and Amortization | $660.94M |
| Dividends Paid | $54.59M |
| Share Repurchases | $1.08B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 10.85%, against a 5-year average of 9.72%.
| Gross Margin | 53.76% |
|---|---|
| Operating Margin | 10.85% |
| Pretax Margin | 10.59% |
| Net Margin | 8.09% |
| EBITDA Margin | 15.15% |
| EBIT Margin | 11.55% |
| FCF Margin | 6.08% |
| Gross Margin (5Y Average) | 51.39% |
| Operating Margin (5Y Average) | 9.72% |
| Net Margin (5Y Average) | 6.76% |
Growth
Revenue grew 9.03% a year over 3 years, and EPS 29.98% a year.
| Revenue Growth (3Y CAGR) | +9.03% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.48% |
| EPS Growth (3Y CAGR) | +29.98% |
| EPS Growth (5Y CAGR) | +14.35% |
| FCF Growth (3Y CAGR) | +47.99% |
| FCF Growth (5Y CAGR) | -12.21% |
| Operating Income Growth (3Y CAGR) | +25.72% |
| Book Value Per Share Growth (2Y CAGR) | +12.17% |
| Tangible Book Per Share Growth (2Y CAGR) | +25.55% |
Dividends and Yields
UHS pays out 2.29% of earnings as dividends.
| Dividend Per Share (Annual) | $0.80 |
|---|---|
| Dividend Yield | 0.42% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | +31.95% |
| Payout Ratio | 2.29% |
| FCF Payout Ratio | 4.90% |
| Earnings Yield | 11.76% |
| FCF Yield | 9.88% |
| Buyback Yield | 9.43% |
| Shareholder Yield | 9.91% |
Stock Splits
The last split was a 2-for-1 forward split on Dec 16, 2009.
| Last Split Date | Dec 16, 2009 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, UHS has the lowest P/E and the 12th highest P/S.
P/E RatioPeer median 21.7x
P/S RatioPeer median 1.6x
ROICPeer median 14.52%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.30%
Dividend YieldPeer median 0.00%
| P/E Ratio | 8.5x vs 21.7x median |
|---|---|
| P/S Ratio | 0.6x vs 1.6x median |
| ROIC | 11.82% vs 14.52% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +8.00% vs +6.30% median |
| Dividend Yield | 0.42% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.95% and EPS growth at 2.83% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.95% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +2.83% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About UHS
What is UHS's market cap?
Universal Health Services has a market cap of $11.40B. Its enterprise value, which adds debt and subtracts cash, is $17.33B.
What is UHS's P/E ratio?
Universal Health Services has a trailing P/E ratio of 8.5x and a forward P/E of 8.4x.
How many shares of UHS are outstanding?
Universal Health Services has 58.80M shares outstanding. The count is down 6.64% from a year earlier.
Does UHS pay a dividend?
Yes. Universal Health Services pays $0.80 a share a year, a dividend yield of 0.42%.
How much debt does UHS have?
Universal Health Services has $6.10B of total debt and $168.75M of cash and equivalents, a net debt position of $5.93B.
UHS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors